SynBioBeta Speaker
Birgit Cameron
Prism Bio, Inc.
CEO, Co-founder
Birgit Cameron is a mission-driven CEO and board member working at the intersection of synthetic biology, food systems, and climate solutions across categories. She co-founded and built Patagonia Provisions alongside Patagonia founder Yvon Chouinard, translating regenerative agriculture and ocean innovations into consumer products at scale. Birgit now leads PrismBio, an AI-enabled biotech color platform developing sustainable, non-petroleum natural colorants across the full visible spectrum using microbial and protein–pigment technologies. She also serves on boards including the Marine Stewardship Council and Atomo Beanless Coffee, bringing a commercial and ecosystem perspective to next-generation ingredients and proteins, and focusing on moving breakthrough science into everyday life without a “green premium.”
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Birgit
This Year
•
-
Planetary Health
Artificial Colours are Out, Bio is In: SynBio’s Opportunity–and Risk–in a Changing Food Landscape
Synthetic biology has long offererd vibrant pigments and functional ingredients with consistency, scalability, and improved sustainability. While many US policy shifts are creating headwinds for biotech innovation, the regulatory momentum around food colors and ingredients could open a significant opportunity for synbio adoption. This session examines the opportunities and risks ahead, highlighting how innovators can align with shifting rules, build trust, and bring bio-based ingredients from lab to label in a rapidly evolving food landscape.
Purchase Pass
•
-
Planetary Health
Artificial Colours are Out, Bio is In: SynBio’s Opportunity–and Risk–in a Changing Food Landscape
Synthetic biology has long offererd vibrant pigments and functional ingredients with consistency, scalability, and improved sustainability. While many US policy shifts are creating headwinds for biotech innovation, the regulatory momentum around food colors and ingredients could open a significant opportunity for synbio adoption. This session examines the opportunities and risks ahead, highlighting how innovators can align with shifting rules, build trust, and bring bio-based ingredients from lab to label in a rapidly evolving food landscape.
Purchase Pass
Session lineup still growing
Purchase Pass
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Purchase Pass
Featuring
Speaker Coming Soon
